Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
4 "Hee Kyung Chang"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study
Haeryoung Kim, Soyeon An, Kyoungbun Lee, Sangjeong Ahn, Do Youn Park, Jo-Heon Kim, Dong-Wook Kang, Min-Ju Kim, Mee Soo Chang, Eun Sun Jung, Joon Mee Kim, Yoon Jung Choi, So-Young Jin, Hee Kyung Chang, Mee-Yon Cho, Yun Kyung Kang, Myunghee Kang, Soomin Ahn, Youn Wha Kim, Seung-Mo Hong, on behalf of the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists
Cancer Res Treat. 2020;52(1):263-276.   Published online July 12, 2019
DOI: https://doi.org/10.4143/crt.2019.192
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The most recent 2017 World Health Organization (WHO) classification of pancreatic neuroendocrine neoplasms (PanNENs) has refined the three-tiered 2010 scheme by separating grade 3 pancreatic neuroendocrine tumors (G3 PanNETs) from poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs). However, differentiating between G3 Pan- NETs and PanNECs is difficult in clinical practice.
Materials and Methods
Eighty-two surgically resected PanNENs were collected from 16 institutions and reclassified according to the 2017 WHO classification based on the histological features and proliferation index (mitosis and Ki-67). Immunohistochemical stains for ATRX, DAXX, retinoblastoma, p53, Smad4, p16, and MUC1 were performed for 15 high-grade PanNENs.
Results
Re-classification resulted in 20 G1 PanNETs (24%), 47 G2 PanNETs (57%), eight G3 well-differentiated PanNETs (10%), and seven poorly differentiated PanNECs (9%). PanNECs showed more frequent diffuse nuclear atypia, solid growth patterns and apoptosis, less frequent organoid growth and regular vascular patterns, and absence of low-grade PanNET components than PanNETs. The Ki-67 index was significantly higher in PanNEC (58.2%± 15.1%) compared to G3 PanNET (22.6%±6.1%, p < 0.001). Abnormal expression of any two of p53, p16, MUC1, and Smad4 could discriminate PanNECs from G3 PanNETs with 100% specificity and 87.5% sensitivity.
Conclusion
Histological features supporting the diagnosis of PanNECs over G3 PanNETs were the absence of a low-grade PanNET component in the tumor, the presence of diffuse marked nuclear atypia, solid growth pattern, frequent apoptosis and markedly increased proliferative activity with homogeneous Ki-67 labeling. Immunohistochemical stains for p53, p16, MUC1, and Smad4 may be helpful in distinguishing PanNECs from G3 PanNETs in histologically ambiguous cases, especially in diagnostic practice when only small biopsied tissues are available.

Citations

Citations to this article as recorded by  
  • Building a diagnostic scoring system for high-grade neuroendocrine neoplasms of the pancreas
    Yuko Kinowaki, Charlotte Wang, Yuki Fukumura, Maria Ganci, M Lisa Zhang, Masanori Kobayashi, Keiichi Akahoshi, Atsushi Kudo, Keiichi Kinowaki, Keita Kai, Yumi Mihara, Ayumi Murakami, Hung Ngoc Nguyen, Ryoichi Hanazawa, Akihiro Hirakawa, Liang Minggao, Mor
    Am J Clin Pathol.2026;[Epub]     CrossRef
  • Prognostic and Predictive Significance of Selected Gene Mutations in Pancreatic and Intestinal Neuroendocrine Tumors
    Jan Musiałkiewicz, Bartłomiej Budny, Aleksandra Anioła, Adam Maciejewski, Paweł Komarnicki, Joanna Maciejewska, Paweł Gut, Marek Ruchała
    International Journal of Molecular Sciences.2026; 27(11): 4874.     CrossRef
  • All Together Now
    Pari Jafari, Aliya N. Husain, Namrata Setia
    Clinics in Laboratory Medicine.2026; 46(3): 577.     CrossRef
  • Treatment status, survival and gene expression analysis of large-cell neuroendocrine lung carcinoma: a real-world study in China
    Fei Qi, Minghang Zhang, Yi Han, Juan Du, Hongjie Yang, Hongmei Zhang, Yong Zhang, Tongmei Zhang
    Therapeutic Advances in Medical Oncology.2025;[Epub]     CrossRef
  • Pancreatic neuroendocrine neoplasms (pNENs): Genetic and environmental biomarkers for risk of occurrence and prognosis
    Matteo Tacelli, Manuel Gentiluomo, Paolo Biamonte, Justo P. Castano, Maja Cigrovski Berković, Mauro Cives, Sanja Kapitanović, Ilaria Marinoni, Sonja Marinovic, Ilias Nikas, Lenka Nosáková, Sergio Pedraza-Arevalo, Eleonora Pellè, Aurel Perren, Jonathan Str
    Seminars in Cancer Biology.2025; 112: 112.     CrossRef
  • Differentiation between G3 pancreatic neuroendocrine tumor and pancreatic neuroendocrine carcinoma based on intratumor and peritumor CT value ratio and abnormal vascular network
    Chaoyang Zhang, Wei Hao
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Malignant potential of neuroendocrine microtumor of the pancreas harboring high-grade transformation: lesson learned from a patient with von Hippel-Lindau syndrome
    Jongwon Lee, Kyung Jin Lee, Dae Wook Hwang, Seung-Mo Hong
    Journal of Pathology and Translational Medicine.2024; 58(2): 91.     CrossRef
  • Rapid Evolution of Metastases in Patients with Treated G3 Neuroendocrine Tumors Associated with NEC-Like Transformation and TP53 Mutation
    Atsuko Kasajima, Nicole Pfarr, Eva-Maria Mayr, Ayako Ura, Elisa Moser, Alexander von Werder, Abbas Agaimy, Marianne Pavel, Günter Klöppel
    Endocrine Pathology.2024; 35(4): 313.     CrossRef
  • The Complex Histopathological and Immunohistochemical Spectrum of Neuroendocrine Tumors—An Overview of the Latest Classifications
    Ancuța-Augustina Gheorghișan-Gălățeanu, Andreea Ilieșiu, Ioana Maria Lambrescu, Dana Antonia Țăpoi
    International Journal of Molecular Sciences.2023; 24(2): 1418.     CrossRef
  • All Together Now
    Pari Jafari, Aliya N. Husain, Namrata Setia
    Surgical Pathology Clinics.2023; 16(1): 131.     CrossRef
  • A systematic review of therapeutic strategies in gastroenteropancreatic grade 3 neuroendocrine tumors
    Mauro D. Donadio, Ângelo B. Brito, Rachel P. Riechelmann
    Therapeutic Advances in Medical Oncology.2023;[Epub]     CrossRef
  • MicroRNAs associated with postoperative outcomes in patients with limited stage neuroendocrine carcinoma of the esophagus
    Tomoyuki Okumura, Tsutomu Fujii, Kenji Terabayashi, Takashi Kojima, Shigeru Takeda, Tomomi Kashiwada, Kazuhiro Toriyama, Susumu Hijioka, Tatsuya Miyazaki, Miho Yamamoto, Shunsuke Tanabe, Yasuhiro Shirakawa, Masayuki Furukawa, Yoshitaka Honma, Isamu Hoshin
    Oncology Letters.2023;[Epub]     CrossRef
  • The association between jaundice and poorly differentiated pancreatic neuroendocrine neoplasms (Ki67 index > 55.0%)
    Yongkang Liu, Jiangchuan Wang, Hao Zhou, Zicheng Wei, Jianhua Wang, Zhongqiu Wang, Xiao Chen
    BMC Gastroenterology.2023;[Epub]     CrossRef
  • An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features
    Atsuko Kasajima, Björn Konukiewitz, Anna Melissa Schlitter, Wilko Weichert, Günter Klöppel
    Virchows Archiv.2022; 480(2): 359.     CrossRef
  • An update on genetically engineered mouse models of pancreatic neuroendocrine neoplasms
    Tiago Bordeira Gaspar, José Manuel Lopes, Paula Soares, João Vinagre
    Endocrine-Related Cancer.2022; 29(12): R191.     CrossRef
  • Solid pancreatic masses in children: A review of current evidence and clinical challenges
    Kelli N. Patterson, Andrew T. Trout, Archana Shenoy, Maisam Abu-El-Haija, Jaimie D. Nathan
    Frontiers in Pediatrics.2022;[Epub]     CrossRef
  • Neuroendocrine Carcinomas with Atypical Proliferation Index and Clinical Behavior: A Systematic Review
    Tiziana Feola, Roberta Centello, Franz Sesti, Giulia Puliani, Monica Verrico, Valentina Di Vito, Cira Di Gioia, Oreste Bagni, Andrea Lenzi, Andrea M. Isidori, Elisa Giannetta, Antongiulio Faggiano
    Cancers.2021; 13(6): 1247.     CrossRef
  • Risk of cancer in patients with recurrent aphthous stomatitis in Korea
    Ki Jin Kwon, Su Jin Jeong, Young-Gyu Eun, In Hwan Oh, Young Chan Lee
    Medicine.2021; 100(16): e25628.     CrossRef
  • Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions
    Anna Pellat, Anne Ségolène Cottereau, Lola-Jade Palmieri, Philippe Soyer, Ugo Marchese, Catherine Brezault, Romain Coriat
    Cancers.2021; 13(10): 2448.     CrossRef
  • Neuroendocrine Carcinomas of the Digestive Tract: What Is New?
    Anna Pellat, Anne Ségolène Cottereau, Benoit Terris, Romain Coriat
    Cancers.2021; 13(15): 3766.     CrossRef
  • Pancreatic Masses in Children and Young Adults: Multimodality Review with Pathologic Correlation
    Lisa Qiu, Andrew T. Trout, Rama S. Ayyala, Sara Szabo, Jaimie D. Nathan, James I. Geller, Jonathan R. Dillman
    RadioGraphics.2021; 41(6): 1766.     CrossRef
  • CD56 Expression Is Associated with Biological Behavior of Pancreatic Neuroendocrine Neoplasms


    Xin Chen, Chuangen Guo, Wenjing Cui, Ke Sun, Zhongqiu Wang, Xiao Chen
    Cancer Management and Research.2020; Volume 12: 4625.     CrossRef
  • Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies
    Lingaku Lee, Tetsuhide Ito, Robert T Jensen
    Expert Review of Anticancer Therapy.2019; 19(12): 1029.     CrossRef
  • 13,721 View
  • 329 Download
  • 21 Web of Science
  • 23 Crossref
Close layer
Inter-observer Reproducibility in the Pathologic Diagnosis of Gastric Intraepithelial Neoplasia and Early Carcinoma in Endoscopic Submucosal Dissection Specimens: A Multi-center Study
Joon Mee Kim, Jin Hee Sohn, Mee-Yon Cho, Woo Ho Kim, Hee Kyung Chang, Eun Sun Jung, Myeong-Cherl Kook, So-Young Jin, Yang Seok Chae, Young Soo Park, Mi Seon Kang, Hyunki Kim, Jae Hyuk Lee, Do Youn Park, Kyoung Mee Kim, Hoguen Kim, Young Ju Suh, Sang Yong Seol, Hwoon-Yong Jung, Deuck–Hwa Kim, Na Rae Lee, Seung-Hee Park, Ji Hye You
Cancer Res Treat. 2019;51(4):1568-1577.   Published online April 1, 2019
DOI: https://doi.org/10.4143/crt.2019.019
AbstractAbstract PDFPubReaderePub
Purpose
The diagnostic criteria of gastric intraepithelial neoplasia (IEN) are controversial across the world. We investigated how many discrepancies occur in the pathologic diagnosis of IEN and early gastric carcinoma in endoscopic submucosal dissection (ESD) specimens, and evaluated the reasons of the discordance.
Materials and Methods
We retrospectively reviewed 1,202 ESD specimens that were originally diagnosed as gastric IEN and early carcinoma at 12 institutions.
Results
The final consensus diagnosis of carcinoma were 756 cases, which were originally 692 carcinomas (91.5%), 43 high-grade dysplasias (5.7%), 20 low-grade dysplasias (2.6%), and 1 others (0.1%), respectively. High- and low-grade dysplasia were finally made in 63 and 342 cases, respectively. The diagnostic concordance with the consensus diagnosis was the highest for carcinoma (91.5%), followed by low-grade dysplasia (86.3%), others (63.4%) and high-grade dysplasia (50.8%). The general kappa value was 0.83, indicating excellent concordance. The kappa values of individual institutions ranged from 0.74 to 1 and correlated with the proportion of carcinoma cases. The cases revised to a final diagnosis of carcinoma exhibited both architectural abnormalities and cytologic atypia. The main differential points between low- and high-grade dysplasias were the glandular distribution and glandular shape. Additional features such as the glandular axis, surface maturation, nuclear stratification and nuclear polarity were also important.
Conclusion
The overall concordance of the diagnosis of gastric IEN and early carcinoma in ESD specimens was excellent. It correlated with the proportion of carcinoma cases, demonstrating that the diagnostic criteria for carcinoma are more reproducible than those for dysplasia.

Citations

Citations to this article as recorded by  
  • An emerging entity of gastric adenocarcinoma: clinicopathological features and differential diagnosis of gastric adenocarcinoma of fundic-gland type in 25 retrospective cases
    Chang Zhao, Bo-Jin Su, Wei-Zhen Lin, An-Fang He, Da-Yang Hui, Hai-Ling Liu, Hui Chen, Ming-Ya Xiao, Jian-Ning Chen, Hai-Feng Li, Jin-Yue Zheng, Wei-Jia Wang, Yan Huang, Chun-Kui Shao
    Virchows Archiv.2026; 488(2): 355.     CrossRef
  • Artificial Intelligence‐Assisted Whole Slide Image Analysis for Lymph Node Status Prediction in Early Colorectal and Gastric Cancer
    Katsuro Ichimasa, Shin‐ei Kudo, Yuta Kouyama, Yuki Takashina, Hyunsoo Chung, Yasuharu Maeda, Wai Phyo Lwin, Yosuke Toya, Waku Hatta, Jimmy Bok Yan So, Khay Guan Yeoh, Tetsuo Nemoto, Masashi Misawa
    Digestive Endoscopy.2026;[Epub]     CrossRef
  • Poor agreement between biopsies and endoscopic submucosal dissection specimens of Esophageal and Gastric Epithelial Lesions in a western setting
    Elisa Cantú-Germano, Glòria Fernández-Esparrach, Alberto Herreros De Tejada, José Carlos Marín-Gabriel, Hugo Uchima, Felipe Ramos-Zabala, Eduardo Albéniz, José Santiago, Oscar Nogales, Enrique Rodríguez De Santiago, Joan B Gornals, Beatriz Peñas, Joaquín
    Digestive and Liver Disease.2025; 57(5): 1006.     CrossRef
  • Development and application of deep learning-based diagnostics for pathologic diagnosis of gastric endoscopic submucosal dissection specimens
    Soomin Ahn, Yiyu Hong, Sujin Park, Yunjoo Cho, Inwoo Hwang, Ji Min Na, Hyuk Lee, Byung-Hoon Min, Jun Haeng Lee, Jae J. Kim, Kyoung-Mee Kim
    Gastric Cancer.2025; 28(4): 609.     CrossRef
  • Efficacy and prognosis analysis of pulley traction-assisted endoscopic submucosal dissection with dental floss for early gastric cancer and precancerous lesions
    Hao Luo, Jie Tang, Xiaotong He, Yinglei Shi, Yunli Chang
    Frontiers in Surgery.2025;[Epub]     CrossRef
  • Seeing the random forest through the decision trees. Supporting learning health systems from histopathology with machine learning models: Challenges and opportunities
    Ricardo Gonzalez, Ashirbani Saha, Clinton J.V. Campbell, Peyman Nejat, Cynthia Lokker, Andrew P. Norgan
    Journal of Pathology Informatics.2024; 15: 100347.     CrossRef
  • A new, simplified endoscopic scoring system for predicting clinical outcome in gastric low-grade intraepithelial neoplasia: the “e-cout system”
    Nanjun Wang, Xiaotong Niu, Longsong Li, Jing Tang, Yawei Bi, Shengzhen Liu, Ke Han, Yaxuan Cheng, Zhaobei Cai, Ningli Chai, Enqiang Linghu
    Neoplasia.2024; 56: 101030.     CrossRef
  • A Prediction Model Based on the Risk Factors Associated with Pathological Upgrading in Patients with Early-Stage Gastric Neoplasms Diagnosed by Endoscopic Forceps Biopsy
    Yu Han Zhao, Yu Zheng, Jie Sha, Hong Jin Hua, Ke Dong Li, Yu Lu, Yi Ni Dang, Guo Xin Zhang
    Gut and Liver.2023; 17(1): 78.     CrossRef
  • A standardized pathology report for gastric cancer: 2nd edition
    Young Soo Park, Myeong-Cherl Kook, Baek-hui Kim, Hye Seung Lee, Dong-Wook Kang, Mi-Jin Gu, Ok Ran Shin, Younghee Choi, Wonae Lee, Hyunki Kim, In Hye Song, Kyoung-Mee Kim, Hee Sung Kim, Guhyun Kang, Do Youn Park, So-Young Jin, Joon Mee Kim, Yoon Jung Choi,
    Journal of Pathology and Translational Medicine.2023; 57(1): 1.     CrossRef
  • Tumor heterogeneity and carcinoma in resected specimens of gastric low-grade dysplasia: A retrospective single center study
    Ga-Yeong Shin, Jun Young Park, Sung Hak Lee, Yu Kyung Cho, Myung-Gyu Choi, Jae Myung Park, Alessandro Rizzo
    PLOS ONE.2023; 18(1): e0280735.     CrossRef
  • A Standardized Pathology Report for Gastric Cancer: 2nd Edition
    Young Soo Park, Myeong-Cherl Kook, Baek-hui Kim, Hye Seung Lee, Dong-Wook Kang, Mi-Jin Gu, Ok Ran Shin, Younghee Choi, Wonae Lee, Hyunki Kim, In Hye Song, Kyoung-Mee Kim, Hee Sung Kim, Guhyun Kang, Do Youn Park, So-Young Jin, Joon Mee Kim, Yoon Jung Choi,
    Journal of Gastric Cancer.2023; 23(1): 107.     CrossRef
  • Accuracy of administrative claim data for gastric adenoma after endoscopic resection
    Ga-Yeong Shin, Hyun Ho Choi, Jae Myung Park, Sang Yoon Kim, Jun Young Park, Donghoon Kang, Yu Kyung Cho, Sung Soo Kim, Myung-Gyu Choi
    Clinical Endoscopy.2023; 56(3): 325.     CrossRef
  • Artificial Intelligence in the Pathology of Gastric Cancer
    Sangjoon Choi, Seokhwi Kim
    Journal of Gastric Cancer.2023; 23(3): 410.     CrossRef
  • Establishment and validation of a clinical diagnostic model for gastric low-grade intraepithelial neoplasia
    Ting Sun, Xi-quan Ke, Meng Wang, Qi-zhi Wang
    Medicine.2023; 102(46): e35515.     CrossRef
  • Assessment of deep learning assistance for the pathological diagnosis of gastric cancer
    Wei Ba, Shuhao Wang, Meixia Shang, Ziyan Zhang, Huan Wu, Chunkai Yu, Ranran Xing, Wenjuan Wang, Lang Wang, Cancheng Liu, Huaiyin Shi, Zhigang Song
    Modern Pathology.2022; 35(9): 1262.     CrossRef
  • Deep learning for automatic diagnosis of gastric dysplasia using whole-slide histopathology images in endoscopic specimens
    Zhongyue Shi, Chuang Zhu, Yu Zhang, Yakun Wang, Weihua Hou, Xue Li, Jun Lu, Xinmeng Guo, Feng Xu, Xingran Jiang, Ying Wang, Jun Liu, Mulan Jin
    Gastric Cancer.2022; 25(4): 751.     CrossRef
  • Documento de posicionamiento de la AEG, la SEED y la SEAP sobre cribado de cáncer gástrico en poblaciones con baja incidencia
    Joaquín Cubiella, Ángeles Pérez Aisa, Miriam Cuatrecasas, Pilar Díez Redondo, Gloria Fernández Esparrach, José Carlos Marín-Gabriel, Leticia Moreira, Henar Núñez, M. Luisa Pardo López, Enrique Rodríguez de Santiago, Pedro Rosón, José Miguel Sanz Anquela,
    Gastroenterología y Hepatología.2021; 44(1): 67.     CrossRef
  • Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP
    Joaquin Cubiella, Ángeles Pérez Aisa, Miriam Cuatrecasas, Pilar Díez Redondo, Gloria Fernández Esparrach, José Carlos Marín-Gabriel, Leticia Moreira, Henar Núñez, M. Luisa Pardo López, Enrique Rodríguez de Santiago, Pedro Rosón, José Miguel Sanz Anquela,
    Gastroenterología y Hepatología (English Edition).2021; 44(1): 67.     CrossRef
  • 12,917 View
  • 267 Download
  • 17 Web of Science
  • 18 Crossref
Close layer
Case Report
Successful Chemotherapy Following Autologous Stem Cell Transplantation in Multiple Myeloma and Multi-organ Dysfunction with Infiltration of Eosinophils: A Case Report
Ho Sup Lee, Lee Chun Park, Seong Hoon Shin, Sang Uk Lee, Hee Kyung Chang, Bang Huh, Gyoo Sik Jung, Mi Hyang Kim, Yang Soo Kim
Cancer Res Treat. 2011;43(3):199-203.   Published online September 30, 2011
DOI: https://doi.org/10.4143/crt.2011.43.3.199
AbstractAbstract PDFPubReaderePub
Eosinophils are derived from hematopoietic stem cells. Peripheral blood eosinophilia is defined as an absolute eosinophil count of > or =0.5x10(9)/L. Eosinophilia is classified into primary or clonal eosinophilia, secondary eosinophilia, and idiopathic categories including idiopathic hypereosinophilic syndrome. Both hematopoietic and solid neoplasms may be associated with peripheral blood eosinophilia, but multiple myeloma is rarely associated with eosinophilia. We now report the case of a 31-year-old man with multiple myeloma associated with marked eosinophilia who developed multiple organ dysfunction with infiltration of eosinophils. He recovered after treatment with chemotherapy followed by autologous stem cell transplantation.

Citations

Citations to this article as recorded by  
  • Eosinophilic granulomatosis with polyangiitis coexisting with multiple myeloma: independent entities or coexistence? A case report
    Longyan Qin, Yi Yin, Pengjia Wu, Aifei Zhang, Na Li, Jun Liu, Ling Huang, Jun Cao, Jiashun Zeng
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • Case Report: A case of non-secretory multiple myeloma presenting with eosinophilia: diagnostic challenges and a focused literature review
    Jirui Zhong, Xikun Liu, Jiduo Liu, Shanshan Xiao, Xuekui Gu, Zenghui Liu
    Frontiers in Oncology.2026;[Epub]     CrossRef
  • DRESS Is Not a Rare Complication during the Initial Treatment of Newly Diagnosed Multiple Myeloma: The Experience of Two Medical Institutes
    Jiao Yang, Qingqing Hu, Jiaqing Lu, Jian Wang, Die Wu, Xiaoming Fei, Lixia Wang, Xianqiu Yu, Yu Tang
    Acta Haematologica.2025; 148(6): 699.     CrossRef
  • Subepidermal Bullous Dermatosis Associated With IgA Multiple Myeloma
    Qiang Zhou, Hao Jiang, Kejian Zhu, Rui Han, Hao Cheng
    The American Journal of Dermatopathology.2013; 35(3): e49.     CrossRef
  • 14,040 View
  • 60 Download
  • 4 Crossref
Close layer
Original Article
Prognostic Significance of Histologic Features, DNA Content, Expression of Proliferating Cell Nuclear Antigen (PCNA), c-fos Protein and Transforming Growth Factor (TGF)-alpha and -beta in Giant Cell Tumor of Bone
Hee Kyung Chang, Sung Hun Yoon, Jae Do Kim, Man Ha Huh
J Korean Cancer Assoc. 1997;29(2):266-279.
AbstractAbstract PDF
PURPOSE
This study was attempted to investigate the prevalence of the expression of c-fos protein, TGF-alpha and -beta, PCNA , DNA ploidy pattern and histopathological parameters of giant cell tumor (GCT) of bone and to correlate with prognosis and to extend our understanding on tumorigenesis of GCT.
MATERIALS AND METHODS
Twenty eight cases of paraffin-embedded tissue were studied, classified as recurrent (5 cases) and non-recurrent group (12cases) within the limits of the cases which afforded surgical material on first operation.
RESULTS
No significant difference was observed in cellularity of stromal cells, atypia of stromal and giant cells, presence of hemorrhage and necrosis between recurrent and non-recurrent group. However, presence of more than 10 mitotic figures in 10 high power fields in recurrent group was significantly higher than non-recurrent group (p<0.05). The immunoreactivity for PCNA was seen only in nuclei of stromal cells, whereas nuclei of giant cells showed negative staining. The positivity of PCNA revealed no significant difference between non-recurrent (mean; 40.9%) and recurrent group (34.4%). The expression of c-fos oncogene was seen in 5 cases (100%) in recurrent group, and 8 cases (66.7%) in non-recurrent group, and no significant difference was seen. No significant difference of expression of TGF-alpha was seen in 5 cases (100%) in recurrent group and in 11 cases (91.7%) in non-recurrent group. The expression of TGF-beta in stromal cells was significantly higher in non-recurrent group (80%) compared to recurrent group (100%) (p<0.05). In DNA analysis out of 18 cases, 4 cases (22.2%) were aneuploidy and 14 cases (77.8%) were diploidy. Among 4 aneuploidy cases, 3 cases (75%) had no recurrence, and 1 case (25%) had metastasis to lung and expired. No significant difference of DNA ploidy pattern was seen between the recurrent and non-recurrent group.
CONCLUSION
Presence of more than 10 mitotic figures in 10 high power fields and less expression of TGF-beta are related to higher possibility of recurrence and it is suggested that the number of mitotic figure (more than 10/10HPF) and expression of TGF-beta could be helpful parameters in predicting recurrence of GCT.
  • 2,831 View
  • 14 Download
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP